TAMSULOSINE VIATRIS L.P. 0.4 mg, extended-release capsule 30 capsules, CIP 3400937076807
Active ingredients: Tamsulosin hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Extended-release capsule30 capsules, CIP 3400937076807orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TAMSULOSINE VIATRIS L.P. 0,4 mg, gélule à libération prolongée
- Pharmaceutical form
- gélule à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 30 gélule(s)
- Marketing authorisation holder
- VIATRIS SANTE
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 10 Mar 2006
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68840153CIP73707680CIP133400937076807Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE TAMSULOSINEgélule | 0,4 mg · une gélule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.